Aimed Bio에임드바이오
0009K0 · KOSDAQ · ₩0009K0 · 에임드바이오
₩20,850▲ ₩300 (1.46%)End-of-day · Oct 28, 2026 · End-of-day prices.
Filings
- Major management matter relevant to investors투자판단관련주요경영사항 (ODS025 기술이전계약 관련 마일스톤 기술료 수령)Oct 27, 2026Open on DART
Predicted impact: Medium
Milestone fee received under ODS025 tech transfer deal; amount not given, revenue base is small.
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인)Sep 22, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 18, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인)Sep 2, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인)Aug 21, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인)Aug 18, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 12, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획승인신청) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청)Aug 10, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획승인신청) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청)Jul 22, 2026Open on DART
- Results of Extraordinary Shareholders' Meeting임시주주총회결과Jul 16, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Jul 16, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획승인신청) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청)Jul 15, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Jul 1, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jun 30, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (ODS025 기술이전계약 관련 마일스톤 기술료 수령)Jun 26, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청등결정) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인)Jun 26, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획승인신청) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청)Jun 16, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Jun 5, 2026Open on DART
- Shareholders' meeting called주주총회소집결의 (임시주주총회)Jun 5, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청)May 27, 2026Open on DART
- Amended: Quarterly report (Mar 2026)[기재정정]분기보고서 (2026.03)May 15, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (ODS025 기술이전계약 관련 연구개발비 수령)May 6, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 27, 2026Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 27, 2026Open on DART
- Earnings Outlook on Consolidated Financial Statements (Fair Disclosure)연결재무제표기준영업실적등에대한전망(공정공시)Mar 26, 2026Open on DART
- Audit report submitted감사보고서제출Mar 19, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 19, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 17, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Mar 17, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 12, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 12, 2026Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 11, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 11, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Feb 27, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Feb 27, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 6, 2026Open on DART
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Feb 6, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 5, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Feb 5, 2026Open on DART
- Change of Head Office Location본점소재지변경Jan 30, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 9, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 9, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 9, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 9, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 9, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (AMB303 공동개발 및 라이선스 계약 관련 옵션행사 기술료 수령)Dec 26, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Dec 22, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 15, 2025Open on DART
- Amended: 5%+ holding report[기재정정]주식등의대량보유상황보고서(약식)Dec 11, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: Aimed Bio / 에임드바이오 / 0009K0 / KRX:0009K0
Source: KRX statistical information